Oakland, CA, United States of America

Robert J A Bell

This inventor holds 1 USPTO granted patent. Top assignees: The United States Government as Represented by the Department of Veterans Affairs, University of California. Active years: 2023.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Robert J A Bell

Introduction

Robert J A Bell is a notable inventor based in Oakland, California. He has made significant contributions to the field of cancer treatment through his innovative research and patents. His work focuses on developing antisense therapies that target specific mutations associated with cancer.

Latest Patents

Robert J A Bell holds a patent for "Antisense therapies for treating cancer." This invention provides methods for addressing cancers associated with a TERT promoter mutation in a subject. The methods involve administering a therapeutically effective amount of an agent that specifically reduces or inhibits GA binding protein transcription factor beta subunit 1 long isoform (GABPBIL) expression or function. This patent highlights his commitment to advancing cancer treatment options.

Career Highlights

Throughout his career, Robert has worked with prestigious institutions, including the University of California and the United States Government as represented by the Department of Veterans Affairs. His experience in these organizations has allowed him to contribute to groundbreaking research and development in the medical field.

Collaborations

Robert has collaborated with esteemed colleagues such as Joseph F Costello and Daniel A Lim. These partnerships have further enhanced his research efforts and have led to significant advancements in cancer therapies.

Conclusion

Robert J A Bell's innovative work in antisense therapies exemplifies his dedication to improving cancer treatment. His contributions to the field are invaluable and continue to inspire future research and development.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…